Literature DB >> 17201816

Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma.

D McCall, S J Hunter, R S Cooke, B Herron, B Sheridan, A B Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17201816     DOI： 10.1111/j.1365-2265.2006.02686.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  6 in total

Review 1.  Medical treatment of prolactinomas.

Authors:  Annamaria Colao; Silvia Savastano
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers.

Authors:  María Susana Mallea-Gil; Carolina Cristina; María Inés Perez-Millan; Ana M Rodriguez Villafañe; Carolina Ballarino; Graciela Stalldecker; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 3.  Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review.

Authors:  L A Behan; M S Draman; C Moran; T King; R K Crowley; E P O'Sullivan; D Smith; C J Thompson; A Agha
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 4.  Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.

Authors:  Claudia Pivonello; Roberta Patalano; Mariarosaria Negri; Rosa Pirchio; Annamaria Colao; Rosario Pivonello; Renata Simona Auriemma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

5.  A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas.

Authors:  Rakesh Mishra; Subhas K Konar; Adesh Shrivastava; Pradeep Chouksey; Sumit Raj; Amit Agrawal
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

6.  Macroprolactinoma causing VI, X, XII cranial nerve palsies nearly 30 years after initial treatment.

Authors:  Anne de Bray; Zaki K Hassan-Smith; Jamal Dirie; Edward Littleton; Swarupsinh Chavda; John Ayuk; Paul Sanghera; Niki Karavitaki
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.